Related references
Note: Only part of the references are listed.Psoriasis and cardiovascular disease risk factors: the HUNT Study, Norway
I. Snekvik et al.
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY (2018)
Factors influencing cardiometabolic risk profile in patients with psoriasis
Neus Curco et al.
AUSTRALASIAN JOURNAL OF DERMATOLOGY (2018)
A systematic review of worldwide epidemiology of psoriasis
I. M. Michalek et al.
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY (2017)
Psoriasis and comorbid diseases Epidemiology
Junko Takeshita et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2017)
An update on psoriasis and metabolic syndrome: A meta-analysis of observational studies
Sanminder Singh et al.
PLOS ONE (2017)
Digestive system in psoriasis: an update
Daniel Pietrzak et al.
ARCHIVES OF DERMATOLOGICAL RESEARCH (2017)
Psoriasis and Cardiovascular Risk: Strength in Numbers Part 3
Alexis Ogdie et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2015)
Psoriasis in the US Medicare Population: Prevalence, Treatment, and Factors Associated with Biologic Use
Junko Takeshita et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2015)
Psoriasis and the Risk of Major Cardiovascular Events: Cohort Study Using the Clinical Practice Research Datalink
Rosa Parisi et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2015)
Prevalence of cardiovascular disease risk factors, and metabolic syndrome and its components in patients with psoriasis aged 30 to 49 years
Agnieszka B. Owczarczyk-Saczonek et al.
POSTEPY DERMATOLOGII I ALERGOLOGII (2015)
Elevated odds of metabolic syndrome in psoriasis: a population-based study of age and sex differences
K. Danielsen et al.
BRITISH JOURNAL OF DERMATOLOGY (2015)
Metabolic syndrome in Spanish patients with psoriasis needing systemic therapy: Prevalence and association with cardiovascular disease in PSO-RISK, a cross-sectional study
I. Belinchon et al.
JOURNAL OF DERMATOLOGICAL TREATMENT (2015)
Metabolic Syndrome Prevalence in Psoriasis
Aurora Parodi et al.
AMERICAN JOURNAL OF CLINICAL DERMATOLOGY (2014)
Psoriasis and Vascular Risk: An Update
Niki Katsiki et al.
CURRENT PHARMACEUTICAL DESIGN (2014)
Endothelial Dysfunction in Chronic Inflammatory Diseases
Curtis M. Steyers et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2014)
Metabolic syndrome and its components in patients with psoriasis
Merce Albareda et al.
SPRINGERPLUS (2014)
The association between psoriasis and dyslipidaemia: a systematic review
C. Ma et al.
BRITISH JOURNAL OF DERMATOLOGY (2013)
Psoriasis, psoriatic arthritis and type 2 diabetes mellitus: a systematic review and meta-analysis
P. Coto-Segura et al.
BRITISH JOURNAL OF DERMATOLOGY (2013)
Comorbidities, metabolic risk profile and health-related quality of life in German patients with plaque-type psoriasis: a cross-sectional prospective study
Arnd Jacobi et al.
INTERNATIONAL JOURNAL OF DERMATOLOGY (2013)
The association between psoriasis and hypertension: a systematic reviewandmeta-analysis of observational studies
April W. Armstrong et al.
JOURNAL OF HYPERTENSION (2013)
Incidence of Cardiovascular Disease in Individuals with Psoriasis: A Systematic Review and Meta-Analysis
Eleanor J. Samarasekera et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2013)
Meta-analysis of psoriasis, cardiovascular disease, and associated risk factors
Iben Marie Miller et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2013)
Psoriasis and the Risk of Diabetes Mellitus A Systematic Review and Meta-analysis
April W. Armstrong et al.
JAMA DERMATOLOGY (2013)
Prevalence of Metabolic Syndrome in Patients with Psoriasis: A Population-Based Study in the United Kingdom
Sinead M. Langan et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2012)
Risk of myocardial infarction in patients with psoriasis
Joel M. Gelfand et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2006)
Mechanisms of disease: atherosclerosis in autoimmune diseases
Y Sherer et al.
NATURE CLINICAL PRACTICE RHEUMATOLOGY (2006)